Asunto(s)
Clostridioides difficile , Infecciones por Clostridium , Adhesión a Directriz , Encuestas de Atención de la Salud , Médicos de Familia , Pautas de la Práctica en Medicina , Antibacterianos/economía , Antibacterianos/uso terapéutico , Clostridioides difficile/efectos de los fármacos , Clostridioides difficile/aislamiento & purificación , Infecciones por Clostridium/diagnóstico , Infecciones por Clostridium/tratamiento farmacológico , Infecciones por Clostridium/microbiología , Diarrea/diagnóstico , Diarrea/tratamiento farmacológico , Diarrea/microbiología , Metronidazol/economía , Metronidazol/uso terapéutico , Guías de Práctica Clínica como Asunto/normas , Pautas de la Práctica en Medicina/tendencias , Vancomicina/economía , Vancomicina/uso terapéuticoAsunto(s)
Colitis/inducido químicamente , Peróxido de Hidrógeno/efectos adversos , Enfermedad Aguda , Colitis/diagnóstico , Colonoscopía , Estreñimiento/tratamiento farmacológico , Diagnóstico Diferencial , Enema , Femenino , Estudios de Seguimiento , Humanos , Peróxido de Hidrógeno/administración & dosificación , Oxidantes/administración & dosificación , Oxidantes/efectos adversos , Índice de Severidad de la Enfermedad , Adulto JovenRESUMEN
OBJECTIVE: To evaluate the practice of otolaryngologists treating reflux-induced upper-respiratory disease in a nationwide survey. STUDY DESIGN: Survey study using an anonymous questionnaire containing clinical vignettes. SUBJECTS AND METHODS: The survey was mailed to all 6,899 board-certified fellow members in practice in the American Academy of Otolaryngology-Head and Neck Surgery residing in the United States. RESULTS: One thousand seven hundred twenty questionnaires were returned. Respondents empirically treated reflux-induced upper-respiratory disease with proton pump inhibitors once daily and twice daily 63% and 31%, respectively. Fifteen percent did not instruct their patients on how to take the proton pump inhibitors. Of those who instructed their patients, 22% advised dosing before breakfast, 32% before breakfast and again before dinner, and 46% recommended other timings. When prescribing twice-per-day dosing, 64% responded to give before breakfast and dinner and 28% responded before breakfast and at bedtime. CONCLUSION: Suboptimal dosing of proton pump inhibitors is prevalent among otolaryngologists treating reflux-induced upper-respiratory disease.